Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Biogen - Wikipedia

    en.wikipedia.org/wiki/Biogen

    Biogen stock is a component of several stock indices such as the S&P 500, S&P 1500, and NASDAQ-100 and the company is listed on the NASDAQ stock exchange under the ticker symbol, BIIB. [11] In May 2006, the company announced it would acquire cancer specialist, Conforma Therapeutics for $250 million. [12]

  3. List of largest biomedical companies by revenue - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...

  4. List of largest biomedical companies by market capitalization

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    List of largest biomedical companies by market capitalization. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization. It does not include biotechnology companies that ...

  5. Biogen Inc Stock Got an Upgrade, but Should You Listen? - AOL

    www.aol.com/news/biogen-inc-stock-got-upgrade...

    Generally speaking, pharmaceuticals are experiencing a mixed year. After a promising start where Biogen shares closed out January up more than 8%, the momentum quickly collapsed. It wasn’t until ...

  6. Is Biogen's Stock Reasonable by the Numbers? - AOL

    www.aol.com/news/2012-01-20-is-biogens-stock...

    Let's see what those numbers can tell us about how expensive or cheap Biogen Idec (NAS: BIIB) might be. The current price multiples First, we'll look at most investors' favorite metric: the P/E ratio.

  7. Biogen to buy Reata for $6.5 billion to bulk up rare ... - AOL

    www.aol.com/news/biogen-buy-reata-6-5-112140242.html

    Biogen said it will pay Reata $172.50 per share in cash, which represents a 58.9% premium to the stock's last closing price. Including debt, the deal values Reata at roughly $7.3 billion.

  8. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [5]

  9. Samsung Biologics - Wikipedia

    en.wikipedia.org/wiki/Samsung_Biologics

    samsungbiologics .com. Samsung Biologics Co., Ltd. is a South Korean biotechnology company headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, it provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry. The company has partnered with pharmaceutical companies such as ...